Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00448071|
Recruitment Status : Unknown
Verified December 2006 by Wolfson Medical Center.
Recruitment status was: Recruiting
First Posted : March 15, 2007
Last Update Posted : March 15, 2007
|Condition or disease||Intervention/treatment||Phase|
|Hypotension End Stage Renal Disease Intra Dialytic Hypotension||Drug: MTR107||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||12 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||A Phase II, Randomized Double Blind Placebo-Controlled, Dose Escalating Study to Determine Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients|
|Study Start Date :||May 2006|
|Study Completion Date :||March 2007|
- A descriptive pharmacokinetic / pharmacodynamic study. No primary end-points apply.
- Exploratory Efficacy Parameters:
- Number and type of medical interventions required for treatment of hypotension.
- Alleviation of symptoms associated with intradialytic hypotension.
- Efficiency of dialysis as reflected by Kt/V
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00448071
|Contact: Zeev Katzir, MD||972-3-5028211|
|Wolfson Medical Center||Recruiting|
|Holon, Israel, 58100|
|Contact: Zeev Katzir, MD 972-3-5028291 email@example.com|
|Principal Investigator: Zeev Katzir, MD|
|Asaf Harofeh Medical Center||Recruiting|
|Rishon Le Zion, Israel, 70300|
|Contact: Shay Efrati, MD 972-8-9778061|
|Principal Investigator: Shay Efrati, MD|
|Principal Investigator:||Zeev Katzir, MD||Wolfson Medical Center|
|Principal Investigator:||Shay Efrati, MD||Asaf Harofeh Medical Center|